HEALTH AND HUMAN SERVICES, DEPARTMENT OF | CENTERS FOR DISEASE CONTROL AND PREVENTION has floated a tender for Oligo CVV Production. The project location is USA and the tender is closing on 27 Aug 2024. The tender notice number is 75D301-24-Q-78627, while the TOT Ref Number is 105870440. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Oligo CVV Production

Deadline : 27 Aug 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 105870440

Document Ref. No. : 75D301-24-Q-78627

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description



See Attached RFQ for Details and Terms

The Contractor shall provide the following:

Single-stranded DNA oligonucleotides: Length is understood to be a significant difference in the construction, processing, and pricing of oligos: For single-stranded DNA oligonucleotides of up to 60 nucleotides (nt) in length: The turnaround time (TAT) will be one (1) business day with an ordering cutoff of 10:00 a.m. EST (to be shipped same-day overnight for next-day delivery). The expected minimum yield will be 25 nMole resuspended at 100 μM in nuclease-free water in a 96-well plate format, with ordering volumes of up to 8 plates per day. For single-stranded DNA oligonucleotides of up to 80 nucleotides (nt) in length: The turnaround time (TAT) will be one (1) business day with an ordering cutoff of 9:00 a.m. EST (to be shipped same-day overnight for next-day delivery). The expected minimum yield will be 25 nMole resuspended in tubes at 100 μM in nuclease-free water. DNA/gene fragments: As with oligos, length is considered a significant factor in the manufacturing of gene fragments, and thus this task can be understood as having different expectations based on length. Double-stranded DNA gene fragments of 300-1, 500bp (base pairs) in length with an error rate of less than 1 bp in 5, 000bp. The turnaround time (TAT) will be three (3) business days with an ordering cutoff of 11:00 a.m. EST (with the ordering date being day 0). The expected minimum yield will be 200ng delivered resuspended at 10 ng/µl in a minimum of 20 µl of nuclease-free water. Double-stranded DNA gene fragments of 1, 501-2, 000bp (base pairs) in length with an error rate of less than 1 bp in 5, 000bp. The turnaround time (TAT) will be eight (8) business days with an expected minimum yield of 1, 000ng delivered lyophilized in tubes (with the ordering date being day 0). Double-stranded DNA gene fragments of 2, 001-2, 250bp (base pairs) in length with an error rate of less than 1 bp in 5, 000bp. The...
Active Contract Opportunity
Notice ID : 75D301-24-Q-78627
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : CENTERS FOR DISEASE CONTROL AND PREVENTION
Office: CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 15, 2024 02:17 pm EDT
Original Date Offers Due: Aug 27, 2024 03:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Sep 11, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: Q301 - REFERENCE LABORATORY TESTING
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance: Atlanta, GA USA

Documents

 Tender Notice

A19.doc